Year: 2014
Type: article
Abstract: A series of pyridine derivatives were synthesized as potential inhibitors of chemokine receptor type 4. This chemokine receptor has been linked to various disease pathways including HIV-1 proliferation, autoimmune disorders, inflammatory diseases, and cancer metastasis. The compounds were tested for activity using an affinity binding assay and an assay that tests the ability to inhibit cell invasion. Two hit compounds ( 2b and 2j ) have been identified for further evaluation that inhibit cell invasion by at least 50% and have an effective concentration of less than 100 n m in the binding affinity assay. The structures of the synthesized compounds were confirmed by spectral data.
Source: Heterocyclic Communications
DOI: 10.1515/hc-2014-0041
Institutions: Georgia State University, Emory University
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: hybrid
Estimated APC paid: $1,808
Funder: National Cancer Institute
Award: G3862931605
OpenAlex ID: W2334489699
